Advanced Search Results For "NON-small-cell lung carcinoma"
Your filters
Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG).
Publication Type: Academic Journal
Source(s): Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Jun; Vol. 183, pp. 109640. Date of Electronic Publication: 2023 Mar 27.
Abstract: Background and Purpose: Radiotherapy is a standard treatment for inoperable stage I non-small cell lung cancer (NSCLC), and carbon-ion radiation therapy (CIRT) may be used for such treatment. Although CIRT for stage I NSCLC has demonstrated favorable o...
Primary Cilia Are Frequently Present in Small Cell Lung Carcinomas but Not in Non-Small Cell Lung Carcinomas or Lung Carcinoids.
Publication Type: Academic Journal
Source(s): Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2023 Feb; Vol. 103 (2), pp. 100007. Date of Electronic Publication: 2023 Jan 10.
Abstract: Most human malignant neoplasms show loss of primary cilia (PC). However, PC are known to be retained and involved in tumorigenesis in some types of neoplasms. The PC status in lung carcinomas remains largely uninvestigated. In this study, we comprehens...
Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case series.
Publication Type: Report
Source(s): Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2023 Jan; Vol. 6 (1), pp. e1754. Date of Electronic Publication: 2022 Nov 11.
Abstract: Background: Large cell neuroendocrine tumors of the lung (LCNEC) are rare. Chemotherapy with the small cell lung carcinoma (SCLC) regimen is the most appropriate treatment for LCNEC. However, there is evidence that the non-small cell lung cancer regime...
Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report.
Publication Type: Academic Journal
Source(s): World journal of surgical oncology [World J Surg Oncol] 2023 Feb 06; Vol. 21 (1), pp. 37. Date of Electronic Publication: 2023 Feb 06.
Abstract: Background: Renal cell carcinoma (RCC) and non-small cell lung cancer (NSCLC) are representative malignancies that respond well to immune checkpoint inhibitors (ICIs). Research has been conducted to identify biomarkers, such as programmed death ligand-...
Cell pellet from fixative medium of transbronchial lung biopsy sample improves lung cancer ancillary test.
Publication Type: Academic Journal
Source(s): Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Jan; Vol. 175, pp. 9-16. Date of Electronic Publication: 2022 Nov 19.
Abstract: Objectives: Lung cancer tissue obtained using small biopsies are relatively fragile, leaving behind some tiny tissue fragments or cell clusters in the fixative medium that are difficult to collect for processing as a paraffin-embedded tissue block. Usu...
Molecular/biomarker testing in lung cytology: A practical approach.
Publication Type: Academic Journal
Source(s): Diagnostic cytopathology [Diagn Cytopathol] 2023 Jan; Vol. 51 (1), pp. 59-67. Date of Electronic Publication: 2022 Sep 13.
Abstract: The increasing comprehension of molecular mechanisms underlying lung cancer and the discovery of targetable genomic alterations has dramatically change the pathological approach to lung cancer, especially non-small cell lung cancer (NSCLC). This unstop...
Targeting YAP1/TAZ in nonsmall-cell lung carcinoma: From molecular mechanisms to precision medicine.
Publication Type: Academic Journal
Source(s): International journal of cancer [Int J Cancer] 2023 Feb 15; Vol. 152 (4), pp. 558-571. Date of Electronic Publication: 2022 Aug 29.
Abstract: Accumulating evidence has underscored the importance of the Hippo-YAP1 signaling in lung tissue homeostasis, whereas its deregulation induces tumorigenesis. YAP1 and its paralog TAZ are the key downstream effectors tightly controlled by the Hippo pathw...
Secular-Trend Analysis of the Incidence Rate of Lung Squamous Cell Carcinoma in Taiwan.
Publication Type: Academic Journal
Source(s): International journal of environmental research and public health [Int J Environ Res Public Health] 2023 Jan 16; Vol. 20 (2). Date of Electronic Publication: 2023 Jan 16.
Abstract: Lung cancer is the leading cause of cancer deaths worldwide, and squamous cell carcinoma (SQC) is Taiwan's second most common lung carcinoma histotype. This study aimed to investigate changes in the long-term trend of the SQC incidence rate in Taiwan. ...
Effect of Chemotherapy in Stage II-IV Large-Cell Lung Carcinoma and Construction of Its Predictive Nomograms: A SEER Analysis.
Publication Type: Academic Journal
Source(s): Medical principles and practice : international journal of the Kuwait University, Health Science Centre [Med Princ Pract] 2023; Vol. 32 (1), pp. 49-60. Date of Electronic Publication: 2023 Jan 18.
Abstract: Objectives: Large-cell lung carcinoma (LCLC) is generally poorly differentiated with a poor prognosis. This study aimed to explore the impact of chemotherapy on the prognosis of patients with stage II-IV LCLC and to construct nomograms to predict overa...
Stereotactic Body Radiation Therapy vs Surgery for Early-Stage Non-Small Cell Lung Cancer: Does the Dealer Influence the Choice?
Publication Type: Academic Journal
Source(s): The Annals of thoracic surgery [Ann Thorac Surg] 2023 Feb; Vol. 115 (2), pp. 354-355. Date of Electronic Publication: 2022 Sep 05.